Table 1.
Characteristics of the study cohort: age groups, exposure to drugs (patients with PDC ≥ 75%), mortality and reinfarction IR*
| Men | Women | Total | ||||
|---|---|---|---|---|---|---|
| 4642 (67.5%) | 2238 (32.5%) | 6880 (100.0%) | ||||
| Age groups (years) † | N | % | N | % | N | % |
| 35–54 | 1155 | 24.9 | 204 | 9.1 | 1359 | 19.8 |
| 55–64 | 1288 | 27.7 | 345 | 15.4 | 1633 | 23.7 |
| 65–74 | 1226 | 26.4 | 579 | 25.9 | 1805 | 26.2 |
| 75–84 | 777 | 16.7 | 770 | 34.4 | 1547 | 22.5 |
| 85–99 | 196 | 4.2 | 340 | 15.2 | 536 | 7.8 |
| Exposure to single drugs | N | % | N | % | N | % |
| Antiplatelet † | 3375 | 72.7 | 1389 | 62.1 | 4764 | 69.2 |
| Beta blockers ‡ | 491 | 10.6 | 205 | 9.2 | 696 | 10.1 |
| ACE inhibitors/sartans ‡ | 2918 | 62.9 | 1371 | 61.3 | 4289 | 62.3 |
| Statins † | 3209 | 69.1 | 1224 | 54.7 | 4433 | 64.4 |
| Outcomes | N | IR * | N | IR * | N | IR * |
| Mortality † | 478 | 41.0 | 363 | 65.7 | 841 | 49.0 |
| Reinfarction † | 462 | 39.7 | 316 | 57.2 | 778 | 45.3 |
IR, incidence ratio; PDC, proportion of days covered.
*
Rates for 1000 person-years.
†
Difference between males and females statistically significant (p < 0.001).
‡
Difference between males and females not statistically significant (p > 0.05).